NCT03441919View on ClinicalTrials.gov

Activation Innate Immune System in Type 1 Diabetes

CompletedOBSERVATIONAL
Enrollment

66

Participants

Timeline

Start Date

January 18, 2018

Primary Completion Date

January 21, 2019

Study Completion Date

January 21, 2019

Conditions
Diabetes Mellitus, Type 1Cardiovascular DiseasesInnate Immune SystemInflammationMetabolism Disorder, Glucose
Interventions
RADIATION

PET-CT (positron emission tomography - computer tomography)

PET-CT to determine vascular inflammation

DIAGNOSTIC_TEST

Blood drawn

Blood drawn

Trial Locations (1)

PO BOX 9101, 6500 HB

Radboud University Nijmegen Medical Centre, Department of Internal Medicine, Nijmegen

All Listed Sponsors
collaborator

European Foundation for the Study of Diabetes

OTHER

lead

Radboud University Medical Center

OTHER

NCT03441919 - Activation Innate Immune System in Type 1 Diabetes | Biotech Hunter | Biotech Hunter